You can Watch our recording by register here: http://ddismart.com/webinar-registration-replay-on-developing-irt-uat-making-the-most-of-your-vendor-partnerships
United Kingdom – 7th March 2017 – The awards team at Corporate LiveWire are pleased to announce the globally awaited Innovation and Excellence awards winners of 2017.
The Innovation and Excellence awards is by far the most celebrated category in the Corporate LiveWire awards recognizing winners for their innovative ideas, global involvement, products, services and much more. The Innovation and Excellence Awards are sponsored by The International Business Innovation Association (InBIA), a global non-profit member network that serves a diverse group of 2,200+ entrepreneurship centers.
Elizabeth Moore, Awards Director of the 2017 Innovation & Excellence Awards commented on the stature of the winners: “I have seen a massive change in innovation going into 2017, billions have been spent in R&D and to work with the most influence people in the industry has been an experience to remember. Our winners have proven to overcome many economic changes and challenges including developments in legislation and politics. I would like to personally congratulate all of our winners and I look forward to seeing further success throughout 2017”.
The judging panel at Corporate LiveWire considered the strengths of each shortlisted candidate, setting its sights firmly on the most innovative, ground-breaking and client-focused firms, teams and individuals who have transformed the way in which they do business. Each winner was chosen on merit and has shown excellence, innovation and strong leadership throughout their various activities over the past calendar year.
DDi has been awarded as winner in Global Excellence in Life Science Technology by Corporate LiveWire for showing excellence by thinking innovatively and utilizing functional domain well, as well as significantly lowering data costs per patient.
DDi’s technology deals with massive data collected from multiple systems, posing the great challenge of maintaining data integrity and correctness. With a series of policies, processes, standards and tools in place, DDi is able to successfully manage their critical data. A move towards standardizing the data and incorporating checks and balances sees that incorrect data is prevented from entering their system and so DDi is able to offer insightful reports in a meaningful way, with correct metadata and mapping that ensures the data flow from source to destination is seamless and presented with utmost accuracy. Indeed, companies need the best IT systems and tools to manage their research and development, and DDi focuses on this highly specialized area, offering e-clinical products and solutions that enable clinical research and trial designs to work with high computing power and analysis.
The partner companies we work with are critical to our success and never more so than when we select and cooperate with an IRT service provider. With a little careful thought and a positive internal approach our partnerships can be streamlined, efficient and rewarding for both sponsor and IRT vendor alike resulting in better IRT systems, built more speedily, at reduced cost and with a fraction of the customary frustration and duplication of effort.
In this session, you’ll learn:
- Appreciating the importance of positive vendor partnerships
- Developing a streamlined sponsor/vendor relationship
- A modern approach to UAT
- Best practices for UAT and beyond
About Our Speaker:
Kate Chapman, the Director of Clinical Technology Consultants Ltd. and the Principal Consultant, Clinical Technology Consultants, Winchester, UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.
What exactly is an IRT system, why is it important in clinical trial, What does your Management demand and what do the IRT providers promise? These are the question the sponsors and clinical trial supply companies faces frequently. DDi is organizing this webinar focusing on the best practices of the IRT systems and Clinical Supplies. IRT system delivers a wide range of applications for managing patient interactions and drug supplies throughout the trial life-cycle. The process includes Patient randomization, Product inventory management, Patient tracking,Study reporting, Drug accountability and reconciliation.But too often challenges arise among the team while juggling many conflicting priorities. With a little careful preparation, and an efficient internal process, IRT development can be achieved in a streamlined fashion delivering an optimum IRT system with a fraction of the customary frustration and duplication of effort.
The points which the webinar will be highlighting are:
Appreciating the importance of IRT
Understanding your own organization
An analysis of previous approaches and the implications thereof
Discussion of best practices
Former Associate Director, IRT Services,
Director & Principal Consultant,
Clinical Technology Consultants Ltd.
Product Specialist, DDi
Kate Chapman, the Director of Clinical Technology Consultants Ltd and the Principal Consultant. Clinical Technology Consultants from Winchester,UK, has 19 years of experience in the Clinical Development area of the Pharmaceutical and Biotechnology sector, with a specialization in IRT. Kate has extensive experience as an end-user of IRT systems and continuously reviews many of the systems that are currently available. She worked with companies like Sandoz, Novartis, Innovex, Roche, Bristol Myers Squibb, Sanofi, Merck, Sharpe and Dohme, Pharmacia, PPD and Emergent Biosciences. Kate most recently formed and led an internal support function dedicated to IRT services and associated disciplines for Shire Pharmaceuticals.
With the FDA and EMA Risk-Based Monitoring (RBM) guidances as well as the upcoming ICH E6 (R2) changes, are you ready for RBM? This webinar will help you assess whether your organization is ready for RBM as well as discuss steps to take to implement RBM. During this webinar you will:
Gain an understanding of RBM in the more general context of Quality Risk Management
Understand the various tools and concepts of RBM
Learn about the foundation for building a Risk Management framework
Understand the steps needed to implement RBM in a Risk Management framework
RN, BSN, MBA, CCRA
Owner/Principal, Maurer Consulting, LLC